Jun 3
|
Top Midday Decliners
|
Jun 2
|
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
May 30
|
Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences
|
May 9
|
Caribou Biosciences, Inc. (NASDAQ:CRBU) Analysts Are Cutting Their Estimates: Here's What You Need To Know
|
May 7
|
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates
|
May 7
|
Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
|
May 1
|
Caribou Biosciences to Participate in Upcoming Investor Conferences
|
Apr 24
|
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Apr 15
|
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
|
Apr 4
|
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
|
Apr 1
|
With 65% institutional ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) is a favorite amongst the big guns
|
Mar 14
|
All You Need to Know About Caribou Biosciences, Inc. (CRBU) Rating Upgrade to Buy
|
Mar 13
|
11 Oversold NASDAQ Stocks To Buy Right Now
|
Mar 12
|
Why Caribou Biosciences Stock Is Crashing Today
|
Mar 11
|
Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
Mar 5
|
Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
|
Feb 26
|
12 $10 Stocks That Will Triple
|
Feb 26
|
Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold
|
Jan 15
|
3 Biotech Stocks You Can Buy and Hold for the Next Decade
|
Dec 8
|
Caribou Biosciences, Inc. (CRBU) Upgraded to Buy: What Does It Mean for the Stock?
|